Insiders Updates Analyzing Allogene Therapeutics Inc (ALLO) After Recent Trading Activity Allogene Therapeutics Inc’s recently made public that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun